Lessee, Operating Lease, Liability, to be Paid of Gain Therapeutics, Inc. from 31 Mar 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Gain Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2024 to 30 Sep 2025.
  • Gain Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2025 was $182,838, a 34% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Gain Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $182,838 -$95,716 -34% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $231,844 -$93,757 -29% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $181,061 -$206,595 -53% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $216,964 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $278,554 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $325,601 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $387,656 31 Mar 2024 10-Q 14 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.